Surgeons at the Department of Neurosurgery, J.N. Medical College, Aligarh Muslim University have performed a rare surgery to ...

“Marketresearch.biz reports that the Global Achondroplasia Market size is expected to be worth around USD 1,189.8 Million by 2033, from USD 70.6 Million in 2024, growing at a CAGR of 33.60% during the ...

BioMarin's other key product, achondroplasia drug Voxzogo, reported strong uptake, helping drive BioMarin's revenue growth. Nutrien (NTR) is the world's largest provider of crop products and services ...

Developmental milestones help us understand when a child needs help, but meeting them early doesn’t necessarily predict ...

BioMarin, the pharmaceutical company based in San Rafael, is laying off 170 employees, or about 5% of its workforce of 3,400.

Parents go to great lengths to see their children happy, and Kory Kosinski’s have done just that by getting him limb ...

Jason Zemansky, an analyst from Bank of America Securities, maintained the Buy rating on BridgeBio Pharma (BBIO – Research Report). The ...

By Mary de Wet BioMarin Pharmaceutical will discontinue certain research and development programs and cut about 170 jobs as part of its strategic ...

TD Cowen analyst Tyler Van Buren has maintained their bullish stance on TYRA stock, giving a Buy rating on May 10. Tyler Van Buren has given ...

U.S. para badminton player Miles Krajewski feels a sense of redemption after punching his ticket to the Paralympics in Paris ...

An actor with a rare genetic condition is captivating audiences with a "dazzling" performance in a televised period drama ...